Abstract
We hypothesized that nandrolone (ND)-abuse induces cardiac hypertrophy, increases myocardial susceptibility to ischemia/reperfusion (I/R) injury, and reduces responsiveness to postconditioning (PostC) cardioprotection. Wistar-rats were ND treated for 2 weeks (short_ND) or 10 weeks (long_ND). Vehicle-treated rats served as controls. Hearts were retrogradely perfused and left ventricular pressure (LVP) was measured before and after 30-min global ischemia. In subgroups of hearts, to induce cardioprotection a PostC protocol (five cycles of 10-s reperfusion and 10-s ischemia) was performed. β-adrenoreceptors, kinases (Akt and GSK-3β) and phosphatases (PP2A sub A and PP2A sub B) were examined by Western blot before and after ischemia. After 120-min reperfusion, infarct size was measured. Short_ND slightly increased cardiac/body weight ratio, but did not affect cardiac baseline nor post-ischemic contractile function or infarct size when compared to vehicle hearts. However, PostC limited cardiac dysfunction much more in short_ND hearts than the other groups. Although cardiac/body weight ratio markedly increased after long_ND, baseline LVP was not affected. Yet, post-ischemic contracture and infarct size were exacerbated and PostC was unable to reduce infarct size and ventricular dysfunction. While short_ND increased phosphatases, non-phosphorylated and phosphorylated Akt, long_ND reduced phosphatase-expression and Akt phosphorylation. Both short_ND and long_ND had no effect on the GSK-3β-phosphorylation but increased the expression of β2-adrenoreceptors. In reperfusion, PostC increased Akt phosphorylation regardless of protective effects, but reduced phosphatase-expression in protected hearts only. In conclusion, short_ND improves post-ischemic myocardial performance in postconditioned hearts. However, long_ND increases myocardial susceptibility to I/R injury and abolishes cardioprotection by PostC. This increased susceptibility might be related to steroid-induced hypertrophy and/or to altered enzyme expression/phosphorylation.
Similar content being viewed by others
References
American Academy of Pediatrics. Committee on Sports Medicine and Fitness (1997) Adolescents and anabolic steroids: a subject review. Pediatrics 99: 904–908. doi:10.1542/peds.99.6.904
Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135. doi:10.1161/CIRCRESAHA.107.164699
Boengler K, Heusch G, Schulz R (2010) Mitochondria in postconditioning. Antioxid Redox Signal. doi:10.1089/ars.2010.3309
Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105:771–785. doi:10.1007/s00395-010-0124-1
Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cadiovasc Res 83:247–261. doi:10.1093/cvr/cvp033
Bokník P, Fockenbrock M, Herzig S, Knapp J, Linck B, Lüss H, Müller FU, Müller T, Schmitz W, Schröder F, Neumann J (2000) Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol 362:222–231. doi:10.1007/s002100000283
Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B (2008) Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295:H1580–H1586. doi:10.1152/ajpheart.00379.2008
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 7:248–254. doi:10.1016/0003-2697(76)90527-3
Chaves EA, Pereira-Junior PP, Fortunato RS, Masuda MO, de Carvalho AC, de Carvalho DP, Oliveira MF, Nascimento JH (2006) Nandrolone decanoate impairs exercise-induced cardioprotection: role of antioxidant enzymes. J Steroid Biochem Mol Biol 99:223–230. doi:10.1016/j.jsbmb.2006.01.004
Cohen MV, Downey JM (2010) Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal. doi:10.1089/ars.2010.3318
Di Lisa F, Canton M, Carpi A, Kaludercic N, Menabò R, Menazza S, Semenzato M (2010) Mitochondrial injury and protection in ischemic pre- and post-conditioning. Antioxid Redox Signal. doi:10.1089/ars.2010.3375
Downey JM, Davis AM, Cohen MV (2007) Signaling pathways in ischemic preconditioning. Heart Fail Rev 12:181–188. doi:10.1007/s10741-007-9025-2
Du Toit EF, Rossouw E, Van Rooyen J, Lochner A (2005) Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury. Cardiovasc J S Afr 16:21–28
El-Armouche A, Gocht F, Jaeckel E, Wittköpper K, Peeck M, Eschenhagen T (2007) Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart. Eur J Heart Fail 9:1077–1080. doi:10.1016/j.ejheart.2007.09.006
Fan WJ, van Vuuren D, Genade S, Lochner A (2010) Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol 105:495–511. doi:10.1007/s00395-010-0086-3
Fantinelli JC, Mosca SM (2007) Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR). Mol Cell Biochem 296:45–51. doi:10.1007/s11010-006-9296-2
Fenton RA, Dickson EW, Dobson JG Jr (2005) Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart. Life Sci 77:3375–3388. doi:10.1016/j.lfs.2005.05.047
Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59:418–458. doi:10.1124/pr.107.06002
Fortunato RS, Marassi MP, Chaves EA, Nascimento JH, Rosenthal D, Carvalho DP (2006) Chronic administration of anabolic androgenic steroid alters murine thyroid function. Med Sci Sport Exerc 38:256–261. doi:10.1249/01.mss.0000183357.19743.51
Gelpi RJ, Morales C, Cohen MV, Downey JM (2002) Xanthine oxidase contributes to preconditioning’s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97:40–46. doi:10.1007/s395-002-8386-0
Hausenloy DJ, Lecour S, Yellon DM (2010) RISK and SAFE pro-survival signalling pathways in ischaemic postconditioning: Two sides of the same coin. Antioxid Redox Signal. doi:10.1089/ars.2010.3360
Hausenloy DJ, Yellon DM (2007) Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116:173–191. doi:10.1016/j.pharmthera.2007.06.005
Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915–1919. doi:10.1161/CIRCULATIONAHA.108.805242
Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 105:151–154. doi:10.1007/s00395-009-0080-9
Iliodromitis EK, Downey JM, Heusch G, Kremastinos DT (2009) What is the optimal postconditioning algorithm? J Cardiovasc Pharmacol Ther 14:269–273. doi:10.1177/1074248409344328
Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295–314. doi:10.1016/j.pharmthera.2010.05.002
LeGros T, McConnell D, Murry T, Edavettal M, Racey-Burns LA, Shepherd RE, Burns AH (2000) The effect of 17 alpha-methyltestosterone on myocardial function in vitro. Med Sci Sports Exer 32:897–903
Li XM, Ma YT, Yang YN, Zhang JF, Chen BD, Liu F, Huang Y, Han W, Gao XM (2009) Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice. Zhonghua Yi Xue Za Zhi 89:846–850
Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW 2nd (2000) Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101:1707–1714
Lindblom J, Kindlundh AM, Nyberg F, Bergström L, Wikberg JE (2003) Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin Mrna levels. Brain Res 986:139–147. doi:10.1016/S0006-8993(03)03223-2
Nasa Y, Yabe K, Takeo S (1997) Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts. J Cardiovasc Pharmacol 29:436–443
Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, Marber MS (2008) Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 103:307–314. doi:10.1161/CIRCRESAHA.107.169953
Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N (2003) Nitroxyl affords thiolsensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34:33–43. doi:10.1016/S0891-5849(02)01179-6
Pagliaro P, Moro F, Tullio F, Perrelli MG, Penna C (2010) Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxid Redox Signal. doi:10.1089/ars.2010.3245
Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644–651. doi:10.1249/01.mss.0000210194.56834.5d
Penna C, Abbadessa G, Mancardi D, Spaccamiglio A, Racca S, Pagliaro P (2007) Nandrolone-pretreatment enhances cardiac beta(2)-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats. J Steroid Biochem Mol Biol 107:106–113. doi:10.1016/j.jsbmb.2007.05.005
Penna C, Abbadessa G, Mancardi D, Tullio F, Piccione F, Spaccamiglio A, Racca S, Pagliaro P (2008) Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2-adrenoceptor. J Physiol Pharmacol 59:645–646
Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 101:168–179. doi:10.1007/s00395-005-0543-6
Penna C, Mancardi D, Raimondo S, Geuna S, Pagliaro P (2008) The paradigm of postconditioning to protect the heart. J Cell Mol Med 12:435–458. doi:10.1111/j.1582-4934.2007.00210.x
Penna C, Mancardi D, Tullio F, Pagliaro P (2008) Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol 103:368–377. doi:10.1007/s00395-007-0695-7
Penna C, Mognetti B, Tullio F, Gattullo D, Mancardi D, Moro F, Pagliaro P, Alloatti G (2009) Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor. Acta Physiol (Oxf) 197:175–185. doi:10.1111/j.1748-1716.2009.02000.x
Penna C, Mognetti B, Tullio F, Gattullo D, Mancardi D, Pagliaro P, Alloatti G (2008) The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. J Physiol Pharmacol 59:47–54
Penna C, Perrelli MG, Raimondo S, Tullio F, Merlino A, Moro F, Geuna S, Mancardi D, Pagliaro P (2009) Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta 787:794–801. doi:10.1016/j.bbabio.2009.03.013
Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning induced cardioprotection requires signaling through a redoxsensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol 101:180–189. doi:10.1007/s00395-006-0584-5
Penna C, Tullio F, Merlino A, Moro F, Raimondo S, Rastaldo R, Perrelli MG, Mancardi D, Pagliaro P (2009) Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol 104:390–402. doi:10.1007/s00395-008-0762-8
Penna C, Tullio F, Moro F, Folino A, Merlino A, Pagliaro P (2010) Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol 105:181–192. doi:10.1007/s00395-009-0075-6
Penson PE, Ford WR, Kidd EJ, Broadley KJ (2008) Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol 378:589–597. doi:10.1007/s00210-008-0331-6
Penson PE, Frod WR, Kidd EJ, Broadley KJ (2008) Protective role of b2- and b3-adrenoceptors at reperfusion in isolated rat heart. J Mol Cell Cardiol 44:719 (Abs19). doi:10.1016/j.yjmcc.2008.02.020
Pesola MK (1988) Reversibility of the haemodynamic effects of anabolic steroids in rats. Eur J Appl Physiol Occup Physiol 58:125–131. doi:10.1007/BF00636615
Przyklenk K, Maynard M, Darling CE, Whittaker P (2008) Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 51:1393–1398. doi:10.1016/j.jacc.2007.11.070
Schulz R, Heusch G (2008) Extracellular adenosine attenuates left ventricular hypertrophy through its impact on the protein kinase and phosphatase interaction. Hypertension 51:1474–1475. doi:10.1161/HYPERTENSIONAHA.108.112144
Schwartz LM, Lagranha CJ (2006) Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia/reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 290:H1011–H1018. doi:10.1152/ajpheart.00864.2005
Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15–18. doi:10.1161/CIRCRESAHA.108.186429
Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104:469–483. doi:10.1007/s00395-009-0040-4
Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15. doi:10.1016/S0033-0620(98)80019-4
Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85–96. doi:10.1038/nrm1837
Tong H, Bernstein D, Murphy E, Steenbergen C (2005) The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 19:983–985. doi:10.1096/fj.04-3067fje
Trifunovic B, Norton GR, Duffield MJ, Avraam P, Woodiwiss AJ (1995) An androgenic steroid decreases left ventricular compliance in rats. Am J Physiol 268:H1096–H1105
Tseng YT, Rockhold RW, Hoskins B, Ho IK (1994) Cardiovascular toxicities of nandrolone and cocaine in spontaneously hypertensive rats. Fundam Appl Toxicol 22:113–121. doi:10.1093/toxsci/22.1.113
Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, Przyklenk K (2010) The multi-dimensional physiological responses to postconditioning. Antioxid Redox Signal. doi:10.1089/ars.2010.3396
Wittköpper K, Eschenhagen T, El-Armouche A (2010) Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress? Basic Res Cardiol 105:569–571. doi:10.1007/s00395-010-0107-2
Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q (2006) Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27:330–337. doi:10.1016/j.tips.2006.04.009
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579–H588. doi:10.1152/ajpheart.01064.2002 (erratum in Am J Physiol Heart Circ Physiol)
Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, Schaub MC, Zaugg M (2006) Ischemic postconditioning protects remodeled myocardium via the PI3 K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 72:152–162. doi:10.1016/j.cardiores.2006.06.027
Acknowledgments
The authors were supported by Compagnia di S. Paolo, National Institutes of Cardiovascular Research (INRC, FM, PP); Regione Piemonte (CP, PP, SR), PRIN (CP, PP), ex-60% (CP, PP, SR). We would thank Prof. D. Gattullo and Dr D. Mancardi for their invaluable support and help.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Penna, C., Tullio, F., Perrelli, MG. et al. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Res Cardiol 106, 409–420 (2011). https://doi.org/10.1007/s00395-010-0143-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00395-010-0143-y